Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/2/2025

Management of Chronic Cough in ESRD Patients

Evidence Against Azithromycin for Chronic Cough

  • The British Thoracic Society guideline explicitly states that long-term macrolide antibiotics are ineffective in improving any outcomes in chronic cough, based on randomized controlled trials totaling 72 patients 1
  • Another randomized trial using erythromycin (a related macrolide) demonstrated no significant difference in 24-hour cough frequency between intervention and placebo groups (p=0.59) 1
  • The only potential subgroup showing benefit was patients with concurrent asthma diagnosis (mean LCQ improvement 6.19), but this was a post-hoc analysis in only 18 patients and requires further validation before clinical application 1

Appropriate Management of 4-Week Chronic Cough

Initial Diagnostic Approach

  • A 4-week cough falls into the subacute category (3-8 weeks), most commonly representing postinfectious cough following a viral upper respiratory infection 2, 3
  • Rule out pneumonia first by checking vital signs (heart rate ≥100, respiratory rate ≥24, temperature ≥38°C) and performing focused lung examination for asymmetrical sounds or consolidation 4
  • Consider pertussis if there are paroxysmal coughing episodes, post-tussive vomiting, or inspiratory whooping sounds—this would warrant macrolide therapy, but for pertussis treatment, not cough suppression 4

Evidence-Based Treatment Options

  • First-generation antihistamine/decongestant combinations are recommended as first-line therapy for upper airway cough syndrome, which commonly causes subacute cough 2, 3
  • Dextromethorphan is recommended for dry, bothersome cough, particularly when disrupting sleep 2
  • Inhaled ipratropium bromide is the only recommended inhaled anticholinergic agent for cough suppression in upper respiratory infections 2
  • Gabapentin may be considered for unexplained chronic cough that persists beyond 8 weeks after discussing potential side effects and risk-benefit profile 5

Critical Pitfalls to Avoid

  • Do not prescribe antibiotics for viral postinfectious cough—this provides no benefit and contributes to antibiotic resistance 2
  • Avoid assuming GERD as the cause without clinical profile features (heartburn, sour taste, regurgitation), as empiric proton pump inhibitor therapy is not recommended for unexplained chronic cough with negative acid reflux workup 5, 6
  • If cough persists beyond 8 weeks despite appropriate treatment, reassess for alternative diagnoses including tuberculosis (especially if from high-prevalence area), malignancy, or ACE inhibitor-induced cough 4